copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
TOUCH On-Line The TOUCH Prescribing Program is designed to: Inform prescribers, infusion center healthcare providers, and patients about the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI including the increased risk of PML with treatment duration and prior immunosuppressant use
TOUCH On-Line To learn more about enrolling in the TOUCH Prescribing Program, contact a TYSABRI Support Specialist at Biogen, call toll free: 1-800-456-2255 Monday-Friday, 8:30 AM to 8:00 PM (ET)
TOUCH On-Line To learn more about enrolling in the TOUCH Prescribing Program, contact a TYSABRI Support Specialist at Biogen, call toll free: 1-800-456-2255 Monday-Friday, 8:30 AM to 8:00 PM (ET)
Please see the Prescribing Information, including BOXED WARNING, What is the TOUCH Prescribing Program? A program that makes TYSABRI® available only to prescribers, infusion centers, pharmacies associated with infusion centers, and patients who are enrolled in the program
Overview of the TOUCH Program The TOUCH Prescribing Program will track all patients over time so that Biogen can inform the FDA, prescribers, and patients in a timely manner of information regarding the safety of TYSABRI
Understanding PML for Gastroenterologists • For prescribers and patients, the TOUCH® Prescribing Program has two components: MS TOUCH® (for patients with multiple sclerosis) and CD TOUCH ® (for patients with Crohn’s disease) • Prescribers must be certified and comply with the following:
Para obtener más información, llama al Guía del Medicamento Prescripción TOUCH® • te solicitará que firmes el Formulario TOUCH® de Inscripción para Paciente y Médico Prescriptor ¿Qué es TYSABRI? TYSABRI es un medicamento recetado que se usa para tratar adultos con: formas recurrentes de Esclerosis Múltiple (EM) incluyendo el síndrome clínicamente aislado, la enfermedad
Please see the Prescribing Information, including BOXED WARNING, for . . . •Provide an overview of the TOUCH Prescribing Program for Multiple Sclerosis (MS) and Crohn’s disease (CD) •Review the process steps to complete TOUCH Prescribing Program components including use of TOUCH On-Line •Review specific MS TOUCH and or CD TOUCH Prescribing Program materials